Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FBnTP PET Imaging in Breast Cancer
NCT02204462Phase 1Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Mar 2015
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: Malignant breast cancer detection. Started Mar 2015; status: terminated.
Beyond the preview
Go deeper on NCT02204462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02204462.